2.3. Gal and NGGAs Target AR/AR-V7 and Mnk1/2-eIF4E Signaling Pathways in Drug-Naïve and Drug-Resistant Prostate Cancer Cell Lines. The gene discussed is MKNK1; the disease is prostate cancer.